Back
Biohaven Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
16
BHVN
Biohaven
Last Price:
$36.44
Seasonality Move:
18.37%
Sell
37
VNDA
Vanda Pharmaceuticals
Last Price:
$4.81
Seasonality Move:
-2.27%
Sell
37
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
-
The current Vanda Pharmaceuticals [VNDA] share price is $4.83. The Score for VNDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
VNDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BHVN Stock Price Chart
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.83The current trend is relatively stagnant and VNDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
BHVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.06 | Sell |
Relative Strength Index (14 RSI): | 32.42 | Sell |
Chaikin Money Flow: | 45611 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.43 - 46.29) | Sell |
Bollinger Bands (100): | (38.23 - 50.29) | Sell |
VNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 51.42 | Buy |
Chaikin Money Flow: | 292919 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.65 - 5.01) | Sell |
Bollinger Bands (100): | (4.64 - 5.2) | Sell |
BHVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.32 | Sell |
20-day SMA: | 41.49 | Sell |
50-day SMA: | 46.69 | Sell |
200-day SMA: | 42.82 | Sell |
8-day EMA: | 37.44 | Sell |
20-day EMA: | 40.61 | Sell |
50-day EMA: | 43.78 | Sell |
200-day EMA: | 41.95 | Sell |
VNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.68 | Buy |
20-day SMA: | 4.79 | Buy |
50-day SMA: | 4.86 | Sell |
200-day SMA: | 5.03 | Sell |
8-day EMA: | 4.72 | Buy |
20-day EMA: | 4.77 | Buy |
50-day EMA: | 4.85 | Sell |
200-day EMA: | 5 | Sell |
Biohaven Earnings Growth & BHVN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.59 per share, and an increase next year of $2.56 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Biohaven Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vanda Pharmaceuticals Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |